Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126478) titled 'Study on the Safety and Efficacy of Rocuronium-Sugammadex Combination in Electroconvulsive Therapy' on June 9.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

Condition: Depression, depressive state

Intervention: Experimental group:Succinylcholine ? rocuronium bromide&sugeng sodium ? succinylcholine ? rocuronium bromide&sugeng sodium (succinylcholine 1mg/kg, rocuronium 0.6mg/kg, sugeng sodium 8mg/kg)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-15

Targe...